The New AI Age in China

A briefing on AI in China by Eric Schmidt's right-hand person and a presentation of a Traditional Chinese Medicine company infused with AI. Rebecca Fannin invites you to join us for to our next group meeting, October 21. 5pm: Registration & Networking 5:30 Welcome and Introductory Remarks 5:40pm Tech chat on China-US AI Race Selina Xu, China and AI Policy Lead Office of Eric Schmidt China technology and AI policy researcher specializing in emerging technologies, AI governance, and U.S.–China technology competition. 6:10pm AI in Traditional Chinese Medicine Howard Jiang, Chairman and CEO, Humanson Inc. An AI drug discovery platform merging Traditional Chinese Medicine with Biomedical Science to treat cancer more effectively and at lower cost. Jiang is a pioneering biotech investor with experience in capital markets, a former corporate lawyer at Baker McKenzie and Troutman, and currently Of Counsel at Becker in the firm's New York and Fort Lauderdale offices. Reception Close: 7:30pm Thanks to our host: Reed Smith LLP (Registration required for event access)